Inventiva S.A. (IVA) stock
IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
$3.22−0.10 (-3.01%)
Close on Nov 17, 2026Market cap $622.22MP/E –Yield –
Inventiva cash
Cash and short-term investments held at the end of each period.
Inventiva's cash was €166.13M at Jun 30, 2026. For fiscal 2025 it was €99.31M, up 2.8% from the year before. The highest annual figure on record is €105.69M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €99.31M | +2.8% |
| FY2024 | Dec 31, 2024 | €96.56M | +258.7% |
| FY2023 | Dec 31, 2023 | €26.92M | -69.0% |
| FY2022 | Dec 31, 2022 | €86.74M | +0.2% |
| FY2021 | Dec 31, 2021 | €86.55M | -18.1% |
| FY2020 | Dec 31, 2020 | €105.69M | +194.9% |
| FY2019 | Dec 31, 2019 | €35.84M | -36.8% |
| FY2018 | Dec 31, 2018 | €56.69M | -4.0% |
| FY2017 | Dec 31, 2017 | €59.05M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | €166.13M | +1537.2% |
| Q4 FY2025 | Dec 31, 2025 | €99.31M | +268.9% |
| Q2 FY2025 | Jun 30, 2025 | €122.08M | +290.8% |
| Q4 FY2024 | Dec 31, 2024 | €96.56M | +11.3% |
| Q2 FY2024 | Jun 30, 2024 | €10.15M | -86.7% |
| Q4 FY2023 | Dec 31, 2023 | €26.92M | -68.9% |
| Q2 FY2023 | Jun 30, 2023 | €31.24M | -70.4% |
| Q4 FY2022 | Dec 31, 2022 | €86.74M | +142.0% |
| Q2 FY2022 | Jun 30, 2022 | €76.41M | +34.8% |
| Q4 FY2021 | Dec 31, 2021 | €86.55M | +46.6% |
| Q4 FY2020 | Dec 31, 2020 | €105.69M | – |
| Q4 FY2019 | Dec 31, 2019 | €35.84M | – |
| Q4 FY2018 | Dec 31, 2018 | €56.69M | – |
| Q4 FY2017 | Dec 31, 2017 | €59.05M | – |
See a number that looks wrong?